{"id":3816,"date":"2019-09-18T06:19:22","date_gmt":"2019-09-18T06:19:22","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/"},"modified":"2019-09-18T06:19:22","modified_gmt":"2019-09-18T06:19:22","slug":"nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/","title":{"rendered":"Nanexas utvidgar samarbetet med globalt animal health-bolag"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><span><strong><\/strong><\/span><\/p>\n<\/div>\n<p><span>Det globala animal health-bolaget som startade utv\u00e4rdering av PharmaShell\u00ae\u00a0i b\u00f6rjan av \u00e5ret har nu beslutat sig f\u00f6r att f\u00f6rl\u00e4nga och utvidga utv\u00e4rderingen. Denna forts\u00e4ttning regleras av samma avtal som tecknades med bolaget i december 2018. Utv\u00e4rderingen syftar till att studera PharmaShell\u00ae-baserade dep\u00e5beredningar med tre olika aktiva l\u00e4kemedelssubstanser i laboratoriemilj\u00f6 samt i djurstudier. Resultaten kommer ligga till grund f\u00f6r eventuellt fortsatt produktutveckling och ut-licensiering av PharmaShell\u00ae-teknologin.<\/span><\/p>\n<p><span>Bolaget bekostar studierna i sin helhet. Nanexa erh\u00e5ller en mindre ers\u00e4ttning f\u00f6r det arbete som genomf\u00f6rs.<\/span><\/p>\n<p><span>F\u00f6retagets VD David Westberg kommenterar:<\/span><\/p>\n<p><span>Den initiala utv\u00e4rderingen av PharmaShell\u00ae\u00a0med bolagets aktiva substanser har fallit v\u00e4l ut. Det \u00e4r d\u00e4rf\u00f6r roligt att de nu vill g\u00e5 vidare i sin utv\u00e4rdering av v\u00e5r drug delivery-plattform PharmaShell\u00ae. Dels med de tv\u00e5 substanser vi redan arbetat med men ocks\u00e5 med till\u00e4gget av en helt ny substans. Med denna ut\u00f6kade utv\u00e4rdering n\u00e4rmar vi oss m\u00f6jligheten att g\u00e5 in i ett mer omfattande samarbete.<\/span><\/p>\n<p><span>F\u00f6r mer information kontakta:<br \/>David Westberg\u00a0\u2013\u00a0VD, Nanexa AB (publ)\u00a0Telefon: 0709 -42 83 03<br \/>E-post: david.westberg@nanexa.se www.nanexa.com<\/span><\/p>\n<p><span>Om Nanexa AB (publ)<\/span><\/p>\n<p><span>Nanexa AB \u00e4r ett drug deliveryf\u00f6retag som fokuserar verksamheten p\u00e5 utvecklingen av PharmaShell\u00aesom ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae\u00a0har Nanexa samarbetsavtal med bland andra AstraZeneca.<\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<p><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/mb.cision.com\/Main\/12591\/2907271\/1107514.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Release<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n<p>Det globala animal health-bolaget som startade utv\u00e4rdering av PharmaShell\u00ae\u00a0i b\u00f6rjan av \u00e5ret har nu beslutat sig f\u00f6r att f\u00f6rl\u00e4nga och utvidga utv\u00e4rderingen. Denna forts\u00e4ttning regleras av samma avtal som tecknades med bolaget i december 2018.<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3816","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexas utvidgar samarbetet med globalt animal health-bolag - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexas utvidgar samarbetet med globalt animal health-bolag - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Det globala animal health-bolaget som startade utv\u00e4rdering av PharmaShell\u00ae\u00a0i b\u00f6rjan av \u00e5ret har nu beslutat sig f\u00f6r att f\u00f6rl\u00e4nga och utvidga utv\u00e4rderingen. Denna forts\u00e4ttning regleras av samma avtal som tecknades med bolaget i december 2018.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\\\/\",\"name\":\"Nanexas utvidgar samarbetet med globalt animal health-bolag - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2019-09-18T06:19:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexas utvidgar samarbetet med globalt animal health-bolag\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexas utvidgar samarbetet med globalt animal health-bolag - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexas utvidgar samarbetet med globalt animal health-bolag - Nanexa AB","og_description":"Det globala animal health-bolaget som startade utv\u00e4rdering av PharmaShell\u00ae\u00a0i b\u00f6rjan av \u00e5ret har nu beslutat sig f\u00f6r att f\u00f6rl\u00e4nga och utvidga utv\u00e4rderingen. Denna forts\u00e4ttning regleras av samma avtal som tecknades med bolaget i december 2018.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/","name":"Nanexas utvidgar samarbetet med globalt animal health-bolag - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2019-09-18T06:19:22+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexas-utvidgar-samarbetet-med-globalt-animal-health-bolag\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexas utvidgar samarbetet med globalt animal health-bolag"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}